Operations

Most platform evaluations score video quality and calendar sync. The things that decide whether you can operate lawfully in a given state are rarely on the scorecard at all.

It is not a national license. It is a fast lane that ends with a separate full license from each state, each one renewed separately. And the states your brand most wants are the ones outside it.

The DEA registration is theirs, their name is on the wall in Texas, and Georgia wants the new protocol filed inside 30 days. Replace the physician in the wrong order and the clinic stops treating.

A white powder looks identical whether it came from a registered facility or a bench in a warehouse. Almost every quality question is decided before the vial is filled.

Made in China is not the problem. Two entirely different supply chains start in the same industrial park, and only one of them has an accountable party.

Almost every peptide sourcing decision we see was made on a phone call. Here are the nine documents to ask for instead, and what the reply tells you.

Full-body imaging, broad biomarker panels, hormones, peptides and infusions — nearly all of it is the practice of medicine. Plus the incidental findings nobody planned for.

Licensure follows the patient, not your company. What a multi-state review network has to deliver for a DTC health brand to actually ship orders.

The difference between a 503A pharmacy and a 503B outsourcing facility decides what you can hold as office stock and what you pay. Plus how to vet a pharmacy partner.

Sending patients elsewhere for bloodwork loses a share of them at the least committed moment. What it takes to draw on site — and to actually close the loop on results.